Williams Jones Wealth Management, Llc. Northwest Biotherapeutics Inc Transaction History
Williams Jones Wealth Management, Llc.
- $7.7 Billion
- Q1 2025
A detailed history of Williams Jones Wealth Management, Llc. transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 27,000 shares of NWBO stock, worth $7,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,000
Previous 27,000
-0.0%
Holding current value
$7,020
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NWBO
# of Institutions
11Shares Held
728KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC500KShares$130,0310.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$17,0490.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,1620.0% of portfolio
-
Alpha Mark Advisors, LLC Ft. Wright, KY14KShares$3,6410.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...